Evidence map›Paper›PMID 12388718›Full record

ArticleJournal of virology2002

Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Brian R Lane, Jianguo Liu, Paul J Bock, Dominique Schols, Michael J Coffey, Robert M Strieter, Peter J Polverini, David M Markovitz

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV Infection.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Trial
  3. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2012
    Trial
  4. Article
  5. The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms.International journal of molecular sciences · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Brian R LaneDivision of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0640, USA.
Jianguo Liu
Paul J Bock
Dominique Schols
Michael J Coffey
Robert M Strieter
Peter J Polverini
David M Markovitz
University of Michigan–Ann Arbor · USOffice of Infectious Diseases · USPulmonary and Critical Care Associates · USKU Leuven · BE

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENFIRE, MELVYN · 1985 to 2007
$40.8M
MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
C-X-C Chemokines and Kaposi's SarcomaR01HL063614 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARKOVITZ, DAVID MICHAEL · 2001 to 2005
$1.5M
REGULATION OF HIV2 TRANSCRIPTION BY THE PETS FACTORR01AI036685 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARKOVITZ, DAVID MICHAEL · 1994 to 2002
$929k
ANGIOGENESIS, ENDOTHELIAL SURVIVAL, AND ORAL CANCERR01DE013161 · NIDCR · UNIVERSITY OF MINNESOTA TWIN CITIES · PI POLVERINI, PETER · 1999 to 2002
$869k
CHEMOKINES AND HIV REPLICATION IN ALVEOLAR MACROPHAGESR01HL057885 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COFFEY, MICHAEL J · 1996 to 2000
$305k
REGULATION OF MACROPHAGE ANGIOGENIC ACTIVITYR01HL039926 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI POLVERINI, PETER · 1988 to 1998
–
SCATTER FACTOR AND AIDS-RELATED KAPOSIS SARCOMAR01CA064416 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI POLVERINI, PETER · 1994 to 1998
–
NCI NIH HHS CA64416NCRR NIH HHS M01 RR000042NCRR NIH HHS M01-RR00042NHLBI NIH HHS HL39926NHLBI NIH HHS HL57885NHLBI NIH HHS HL63614NHLBI NIH HHS R01 HL063614NIAID NIH HHS AI 07528NIAID NIH HHS AI36685NIAID NIH HHS T32 AI007528NIDCR NIH HHS DE13161NIGMS NIH HHS GM07315NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32 GM007863NIGMS NIH HHS T32 GM07863
6 · The paper itself

Abstract

The development of the complex neoplasm Kaposi's sarcoma is dependent on infection with the Kaposi's sarcoma-associated herpesvirus (KSHV) and appears to be greatly enhanced by cytokines and human immunodeficiency virus type 1 (HIV-1) Tat. Interleukin-8 (IL-8) and growth-regulated oncogene alpha (GRO-alpha) are chemokines involved in chemoattraction, neovascularization, and stimulation of HIV-1 replication. We have previously demonstrated that production of GRO-alpha is stimulated by exposure of monocyte-derived macrophages (MDM) to HIV-1. Here we show that exposure of MDM to HIV-1, viral Tat, or viral gp120 leads to a substantial increase in IL-8 production. We also demonstrate that IL-8 and GRO-alpha are induced by KSHV infection of endothelial cells and are crucial to the angiogenic phenotype developed by KSHV-infected endothelial cells in cell culture and upon implantation into SCID mice. Thus, the three known etiological factors in Kaposi's sarcoma pathogenesis-KSHV, HIV-1 Tat, and cellular growth factors-might be linked, in part, through induction of IL-8 and GRO-alpha.

Indexed as

Chemokines, CXCNeovascularization, PathologicAnimalsCell LineCell TransplantationChemokine CXCL1ChemokinesChemotactic FactorsDisease Models, AnimalGene Products, tatHIV-1HIV Envelope Protein gp120HumansIntercellular Signaling Peptides and ProteinsInterleukin-8Leukocytes, MononuclearChemokine CXCL1ChemokinesChemokines, CXCChemotactic FactorsCXCL1 protein, humanCxcl1 protein, mouseGene Products, tatHIV Envelope Protein gp120Intercellular Signaling Peptides and ProteinsInterleukin-8tat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID12388718
PMCPMC136744
OpenAlexW2120499790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.